Sonoma Pharmaceuticals, Inc.
SNOA
$2.97
$0.051.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.33% | -0.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.33% | -0.42% | |||
| Cost of Revenue | -2.96% | 3.43% | |||
| Gross Profit | 20.31% | -6.69% | |||
| SG&A Expenses | -5.39% | 9.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.03% | 3.75% | |||
| Operating Income | 36.37% | -21.29% | |||
| Income Before Tax | 42.55% | -98.49% | |||
| Income Tax Expenses | 2,655.56% | -93.88% | |||
| Earnings from Continuing Operations | 16.38% | -52.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.38% | -52.13% | |||
| EBIT | 36.37% | -21.29% | |||
| EBITDA | 37.37% | -22.45% | |||
| EPS Basic | 24.10% | -7.46% | |||
| Normalized Basic EPS | 47.85% | -40.16% | |||
| EPS Diluted | 24.10% | -7.46% | |||
| Normalized Diluted EPS | 47.85% | -40.16% | |||
| Average Basic Shares Outstanding | 10.18% | 41.59% | |||
| Average Diluted Shares Outstanding | 10.18% | 41.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||